Global Synthetic Biology Market to Reach USD 66.7 Billion by 2033, Stimulated by Increasing Demand for Sustainable Solutions

November 13, 2024 | Healthcare

According to the latest report by IMARC Group, titled “Synthetic Biology Market Report by Product (Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-nucleic Acids, Chassis Organism), Technology (NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, and Others), Application (Healthcare, Non-Healthcare), and Region 2025-2033,” the global synthetic biology market size reached USD 18.5 Billion in 2024. Synthetic biology refers to an interdisciplinary field that combines principles from biology, engineering, and computer science to design and construct new biological parts, devices, and systems. It aims to engineer living organisms or create artificial biological systems with specific functions. Synthetic biologists utilize advanced techniques, such as gene synthesis, genetic engineering, and genome editing to manipulate the genetic code of organisms and create novel biological functionalities. The applications of synthetic biology are vast and diverse, ranging from the development of sustainable biofuels, bio-based materials, and pharmaceuticals to the creation of genetically modified organisms for environmental remediation and disease treatment. The field holds great promise in revolutionizing various industries and addressing complex global challenges, positioning it at the forefront of scientific research and innovation.

Global Synthetic Biology Market Trends:

The increasing demand for sustainable and environmentally friendly solutions is driving the global market. By leveraging genetic engineering techniques, synthetic biology offers the potential to create biodegradable materials, eco-friendly chemicals, and renewable energy sources, reducing the reliance on fossil fuels and mitigating the impact of human activities on the environment. Moreover, ongoing advancements in gene editing technologies have accelerated progress in synthetic biology since these powerful tools allow researchers to precisely edit the genetic code of organisms, enabling faster and more precise engineering of biological systems. Moreover, the growing interest and investment from both the public and private sectors have significantly contributed to the expansion of the synthetic biology market. Governments and companies recognize the immense potential of synthetic biology to drive innovation and economic growth and address critical challenges in healthcare, agriculture, and industrial production. Furthermore, the openness and accessibility of genetic data and biotechnological tools have enabled a broader community of researchers and entrepreneurs to participate in the synthetic biology ecosystem. Looking forward, the market value is projected to reach USD 66.7 Billion by 2033, expanding at a CAGR of 15.3% during 2025-2033.

Market Summary:

  • Based on the product, the market has been segmented into oligonucleotide/oligo pools and synthetic DNA, enzymes, cloning technologies kits, Xeno-nucleic acids, chassis organism.
  • On the basis of technology, the market has been divided into NGS, PCR, genome editing, bioprocessing, and other technologies.
  • Based on the application, the market has been bifurcated into healthcare (clinical, and non-clinical/research), and non-healthcare (biotech crops, specialty chemicals, bio-fuels, and others).
  • Region-wise, the market has been segmented into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being Agilent Technologies Inc., Amyris Inc., Codexis Inc., Danaher Corporation, Eurofins Scientific, GenScript Biotech Corporation, Illumina Inc., Merck KGaA, New England Biolabs, Synthego Corporation, Thermo Fisher Scientific Inc., Twist Bioscience and Viridos Inc.
     

Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Product, Technology, Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Agilent Technologies Inc., Amyris Inc., Codexis Inc., Danaher Corporation, Eurofins Scientific, GenScript Biotech Corporation, Illumina Inc., Merck KGaA, New England Biolabs, Synthego Corporation, Thermo Fisher Scientific Inc., Twist Bioscience and Viridos Inc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Synthetic Biology Market to Reach USD 66.7 Billion by 2033, Stimulated by Increasing Demand for Sustainable Solutions
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials